Zapof

Comprehensive Deviation Reporting & CAPA Management System

1. Section 1: Batch Identification, Molecule & Production Line Details

This section captures critical traceability information to ensure complete batch genealogy and equipment history. Accurate data entry is essential for regulatory compliance and investigation integrity.

 

Batch Identification Number

Molecule/Product Name

Product Code/SKU

Primary Production Line Identifier

 

Specify Sterile Line Classification:

 

Specify Other Production Line:

Equipment IDs Directly Involved in Deviation

Current Production Phase When Deviation Detected

 

Specify QC Test Method:

 

Specify Other Production Phase:

Date and Time of Deviation Detection

Estimated Date and Time of Actual Deviation Occurrence

Technician Employee ID/Badge Number

Supervisor on Duty

Shift Identifier

Witnesses to Deviation Event

Witness Name

Role/Position

Contact Information

A
B
C
1
 
 
 
2
 
 
 
3
 
 
 
4
 
 
 
5
 
 
 
6
 
 
 
7
 
 
 
8
 
 
 
9
 
 
 
10
 
 
 

2. Section 2: Deviation Description & Process Metric Delta Assessment

Provide comprehensive details of the deviation including quantified process metric variations. Attach all relevant evidence including trend charts, photographs, and analytical results to support the investigation.

 

Deviation Classification Category

 

Describe Yield Loss Mechanism:

 

Specify Physical Parameter Affected:

 

Equipment Failure Mode Description:

 

Describe Contamination Event:

Detailed Deviation Description

Critical Process Parameters Affected

Process Metric Delta Quantification

Parameter Name

Expected Value/Range

Actual Value Observed

Deviation Magnitude

Unit of Measure

% Deviation from Spec

A
B
C
D
E
F
1
 
 
 
0
 
0
2
 
 
 
0
 
0
3
 
 
 
 
 
0
4
 
 
 
 
 
0
5
 
 
 
 
 
0
6
 
 
 
 
 
0
7
 
 
 
 
 
0
8
 
 
 
 
 
0
9
 
 
 
 
 
0
10
 
 
 
 
 
0

Deviation Severity Rating (1=Minor, 5=Critical)

Impact Assessment Matrix

Negligible

Low

Medium

High

Critical

Product Quality Impact

Patient Safety Risk

Regulatory Compliance Risk

Supply Chain Disruption

Financial Impact

Upload Visual Evidence (Photos, Screenshots, Trend Charts)

Choose a file or drop it here

Attach Analytical Reports, Printouts, or Data Files

Choose a file or drop it here
 

Was this deviation associated with an Out-of-Specification (OOS) result?

 

OOS Investigation Reference Number:

3. Section 3: Immediate Product Hold & Quarantine Log

Document all immediate containment actions taken to prevent further processing or distribution of potentially impacted materials. This section is critical for maintaining product control and regulatory compliance.

 

Is Immediate Product Hold Required?

 

Justification for Immediate Hold:

 

Risk Assessment for Not Placing Hold:

Hold Initiated By (Name & Role)

Hold Implementation Date/Time

Physical Quarantine Location/Bay Number

Affected Batch Inventory Details

Batch/Lot Number

Quantity

Unit

Status

Storage Conditions

A
B
C
D
E
1
 
0
 
Hold
 
2
 
0
 
Hold
 
3
 
 
 
 
 
4
 
 
 
 
 
5
 
 
 
 
 
6
 
 
 
 
 
7
 
 
 
 
 
8
 
 
 
 
 
9
 
 
 
 
 
10
 
 
 
 
 

Quarantine Conditions Maintained

I confirm that quarantine labels and physical segregation have been applied to all affected materials

Departments Notified of Hold Status

Proposed Release Criteria or Disposition

4. Section 4: Root Cause Analysis & Corrective/Preventive Action (CAPA) Plan

Conduct thorough root cause analysis using appropriate methodologies. Develop comprehensive CAPA plans with measurable outcomes and clear accountability. Attach all investigation tools used (Fishbone diagrams, 5-Why analysis, etc.).

 

Root Cause Analysis Methodology Applied

Root Cause Category

Detailed Root Cause Statement

Contributing Factors Identified

Does this deviation require a formal CAPA Plan?

 

CAPA Action Plan Matrix

Action Item Description

Action Type

Responsible Owner

Target Completion Date

Effectiveness Metric

Priority (1=Low, 5=Critical)

A
B
C
D
E
F
1
 
 
 
6/30/2025
 
 
2
 
 
 
7/15/2025
 
 
3
 
 
 
 
 
 
4
 
 
 
 
 
 
5
 
 
 
 
 
 
6
 
 
 
 
 
 
7
 
 
 
 
 
 
8
 
 
 
 
 
 
9
 
 
 
 
 
 
10
 
 
 
 
 
 

Justification for No Formal CAPA:

Immediate Containment Actions Already Taken

Risk Assessment Post-CAPA Implementation

Probability of Recurrence

Detection Capability

Severity of Impact

Will CAPA effectiveness require validation studies?

 

Validation Protocol Requirements:

Attach Root Cause Analysis Documentation (Fishbone, 5-Why, etc.)

Choose a file or drop it here
 

5. Section 5: Quality Director & Regulatory Affairs Clearance Sign-Off

Final review and authorization by Quality and Regulatory leadership. This section confirms that appropriate investigation has been completed, risk has been assessed, and regulatory obligations have been evaluated before final disposition.

 

Quality Review Status

 

Specify Conditions for Approval:

 

Explain CAPA Deficiencies:

 

List Required Additional Information:

Does this deviation have potential regulatory reporting implications?

 

Applicable Regulatory Agencies/Markets

Quality Director Name

Quality Director Digital Signature

Quality Director Sign-Off Date

Quality Director Review Comments

Regulatory Affairs Approver Name

Regulatory Affairs Digital Signature

Regulatory Affairs Sign-Off Date

Regulatory Affairs Assessment & Comments

Final Batch Disposition Decision

I certify that this deviation has been thoroughly investigated in accordance with cGMP principles and all applicable regulatory requirements

I confirm that all relevant departments have been notified and appropriate risk mitigation measures are in place

 

To configure an element, select it on the form.

To add a new question or element, click the Question & Element button in the vertical toolbar on the left.